語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Biopharmaceutical Applied Statistics...
~
Chen, Ding-Geng.
Biopharmaceutical Applied Statistics Symposium = Volume 2 Biostatistical Analysis of Clinical Trials /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Biopharmaceutical Applied Statistics Symposium / edited by Karl E. Peace, Ding-Geng Chen, Sandeep Menon.
其他題名:
Volume 2 Biostatistical Analysis of Clinical Trials /
其他作者:
Peace, Karl E.
面頁冊數:
XIII, 245 p. 34 illus., 18 illus. in color.online resource. :
Contained By:
Springer Nature eBook
標題:
Statistics . -
電子資源:
https://doi.org/10.1007/978-981-10-7826-2
ISBN:
9789811078262
Biopharmaceutical Applied Statistics Symposium = Volume 2 Biostatistical Analysis of Clinical Trials /
Biopharmaceutical Applied Statistics Symposium
Volume 2 Biostatistical Analysis of Clinical Trials /[electronic resource] :edited by Karl E. Peace, Ding-Geng Chen, Sandeep Menon. - 1st ed. 2018. - XIII, 245 p. 34 illus., 18 illus. in color.online resource. - ICSA Book Series in Statistics,2199-0980. - ICSA Book Series in Statistics,.
On Statistical Approaches to Meta-analysis of Randomized Clinical Trials -- Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies -- Generalized Tests in Clinical Trials -- Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free -- Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia -- Some Statistical Issues in Patient-reported Outcomes -- Network Meta-analysis -- Detecting Safety Signals Among Adverse Events in Clinical Trials -- Applied Meta-analysis using R -- Treatment of Missing Data in Comparative Effectiveness Research -- Missing Data -- Bayesian Subgroup Analysis with Examples -- Statistical Methods in Diagnostic Devices -- A Question-Based Approach to the Analysis of Safety Data -- Analysis of Two-stage Adaptive Seamless Trial Design -- Multiplicity Problems in Clinical Trials – A Regulatory Perspective.
This BASS book Series publishes selected high-quality papers reflecting recent advances in the design and biostatistical analysis of biopharmaceutical experiments – particularly biopharmaceutical clinical trials. The papers were selected from invited presentations at the Biopharmaceutical Applied Statistics Symposium (BASS), which was founded by the first Editor in 1994 and has since become the premier international conference in biopharmaceutical statistics. The primary aims of the BASS are: 1) to raise funding to support graduate students in biostatistics programs, and 2) to provide an opportunity for professionals engaged in pharmaceutical drug research and development to share insights into solving the problems they encounter. The BASS book series is initially divided into three volumes addressing: 1) Design of Clinical Trials; 2) Biostatistical Analysis of Clinical Trials; and 3) Pharmaceutical Applications. This book is the second of the 3-volume book series. The topics covered include: Statistical Approaches to the Meta-analysis of Randomized Clinical Trials, Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies, Generalized Tests in Clinical Trials, Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free , Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia, Selected Statistical Issues in Patient-reported Outcomes, Network Meta-analysis, Detecting Safety Signals Among Adverse Events in Clinical Trials, Applied Meta-analysis Using R, Treatment of Missing Data in Comparative Effectiveness Research, Causal Estimands: A Common Language for Missing Data, Bayesian Subgroup Analysis with Examples, Statistical Methods in Diagnostic Devices, A Question-Based Approach to the Analysis of Safety Data, Analysis of Two-stage Adaptive Seamless Trial Design, and Multiplicity Problems in Clinical Trials – A Regulatory Perspective.
ISBN: 9789811078262
Standard No.: 10.1007/978-981-10-7826-2doiSubjects--Topical Terms:
1253516
Statistics .
LC Class. No.: QA276-280
Dewey Class. No.: 519.5
Biopharmaceutical Applied Statistics Symposium = Volume 2 Biostatistical Analysis of Clinical Trials /
LDR
:04572nam a22004215i 4500
001
989905
003
DE-He213
005
20200704144624.0
007
cr nn 008mamaa
008
201225s2018 si | s |||| 0|eng d
020
$a
9789811078262
$9
978-981-10-7826-2
024
7
$a
10.1007/978-981-10-7826-2
$2
doi
035
$a
978-981-10-7826-2
050
4
$a
QA276-280
072
7
$a
PBT
$2
bicssc
072
7
$a
MED090000
$2
bisacsh
072
7
$a
PBT
$2
thema
072
7
$a
MBNS
$2
thema
082
0 4
$a
519.5
$2
23
245
1 0
$a
Biopharmaceutical Applied Statistics Symposium
$h
[electronic resource] :
$b
Volume 2 Biostatistical Analysis of Clinical Trials /
$c
edited by Karl E. Peace, Ding-Geng Chen, Sandeep Menon.
250
$a
1st ed. 2018.
264
1
$a
Singapore :
$b
Springer Singapore :
$b
Imprint: Springer,
$c
2018.
300
$a
XIII, 245 p. 34 illus., 18 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
490
1
$a
ICSA Book Series in Statistics,
$x
2199-0980
505
0
$a
On Statistical Approaches to Meta-analysis of Randomized Clinical Trials -- Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies -- Generalized Tests in Clinical Trials -- Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free -- Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia -- Some Statistical Issues in Patient-reported Outcomes -- Network Meta-analysis -- Detecting Safety Signals Among Adverse Events in Clinical Trials -- Applied Meta-analysis using R -- Treatment of Missing Data in Comparative Effectiveness Research -- Missing Data -- Bayesian Subgroup Analysis with Examples -- Statistical Methods in Diagnostic Devices -- A Question-Based Approach to the Analysis of Safety Data -- Analysis of Two-stage Adaptive Seamless Trial Design -- Multiplicity Problems in Clinical Trials – A Regulatory Perspective.
520
$a
This BASS book Series publishes selected high-quality papers reflecting recent advances in the design and biostatistical analysis of biopharmaceutical experiments – particularly biopharmaceutical clinical trials. The papers were selected from invited presentations at the Biopharmaceutical Applied Statistics Symposium (BASS), which was founded by the first Editor in 1994 and has since become the premier international conference in biopharmaceutical statistics. The primary aims of the BASS are: 1) to raise funding to support graduate students in biostatistics programs, and 2) to provide an opportunity for professionals engaged in pharmaceutical drug research and development to share insights into solving the problems they encounter. The BASS book series is initially divided into three volumes addressing: 1) Design of Clinical Trials; 2) Biostatistical Analysis of Clinical Trials; and 3) Pharmaceutical Applications. This book is the second of the 3-volume book series. The topics covered include: Statistical Approaches to the Meta-analysis of Randomized Clinical Trials, Collaborative Targeted Maximum Likelihood Estimation to Assess Causal Effects in Observational Studies, Generalized Tests in Clinical Trials, Discrete Time-to-event and Score-based Methods with Application to Composite Endpoint for Assessing Evidence of Disease Activity-Free , Imputing Missing Data Using a Surrogate Biomarker: Analyzing the Incidence of Endometrial Hyperplasia, Selected Statistical Issues in Patient-reported Outcomes, Network Meta-analysis, Detecting Safety Signals Among Adverse Events in Clinical Trials, Applied Meta-analysis Using R, Treatment of Missing Data in Comparative Effectiveness Research, Causal Estimands: A Common Language for Missing Data, Bayesian Subgroup Analysis with Examples, Statistical Methods in Diagnostic Devices, A Question-Based Approach to the Analysis of Safety Data, Analysis of Two-stage Adaptive Seamless Trial Design, and Multiplicity Problems in Clinical Trials – A Regulatory Perspective.
650
0
$a
Statistics .
$3
1253516
650
0
$a
Biostatistics.
$3
783654
650
1 4
$a
Statistics for Life Sciences, Medicine, Health Sciences.
$3
670172
700
1
$a
Peace, Karl E.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1132099
700
1
$a
Chen, Ding-Geng.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
848229
700
1
$a
Menon, Sandeep.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1208724
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9789811078255
776
0 8
$i
Printed edition:
$z
9789811078279
776
0 8
$i
Printed edition:
$z
9789811340079
830
0
$a
ICSA Book Series in Statistics,
$x
2199-0980
$3
1255207
856
4 0
$u
https://doi.org/10.1007/978-981-10-7826-2
912
$a
ZDB-2-SMA
912
$a
ZDB-2-SXMS
950
$a
Mathematics and Statistics (SpringerNature-11649)
950
$a
Mathematics and Statistics (R0) (SpringerNature-43713)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入